CellWell record HH-537633
EGFR Signaling in Colorectal Cancer: Novel Therapeutic Strategies, Predictive Biomarkers, and Counteracting Treatment Resistance
Noura Abbas; Mohamad Mourad; Hiba Smaily; Layal Al Mahmasani; Ali Shamseddine
2026
In plain language
This review synthesizes EGFR signaling in colorectal cancer and identifies RAS and BRAF mutations and MSI status as predictive biomarkers for anti-EGFR therapy response and resistance.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-537633
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.